The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

NU Skin Enterprises Inc

NYSE: NUS
Last

(U.S.) $55.48

Today's change+1.70 +3.16%
Updated August 18 4:02 PM EDT. Delayed by at least 15 minutes.
 

NU Skin Enterprises Inc

NYSE: NUS
Last

(U.S.) $55.48

Today's change+1.70 +3.16%
Updated August 18 4:02 PM EDT. Delayed by at least 15 minutes.

NU Skin Enterprises Inc crosses above 200-day moving average

NU Skin Enterprises Inc closed up sharply Friday, rallying (U.S.)$1.70 or 3.16% to (U.S.)$55.48 and crossing above its 200-day moving average. Shares have lost 8.33% over the last five days, but have gained 16.12% over the last year to date. This security has underperformed the S&P 500 by 16.79% during the last year.

Key company metrics

  • Open(U.S.) $53.79
  • Previous close(U.S.) $53.78
  • High(U.S.) $55.55
  • Low(U.S.) $53.77
  • Bid / Ask-- / --
  • YTD % change+16.12%
  • Volume995,807
  • Average volume (10-day)1,071,053
  • Average volume (1-month)681,318
  • Average volume (3-month)618,805
  • 52-week range(U.S.) $46.35 to (U.S.) $66.04
  • Beta1.42
  • Trailing P/E18.76×
  • P/E 1 year forward17.17×
  • Forward PEG1.97×
  • Indicated annual dividend(U.S.) $1.44
  • Dividend yield2.60%
  • Trailing EPS(U.S.) $2.96
Updated August 18 4:02 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+7.53%

Based on its net profit margin of 7.53%, NU Skin Enterprises Inc is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.54%Sector:Non-Cyclical Consumer Goods & ServicesIndustry:Personal Products
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2017Q1/2017Q4/2016Q3/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016
Revenue550499531604
Total other revenue--------
Total revenue550499531604
Gross profit429388423478
Total cost of revenue122111109126
Total operating expense485453471522
Selling / general / administrative364342362396
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income65466182
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax62426277
Income after tax42273857
Income tax, total20142420
Net income42273857
Total adjustments to net income--------
Net income before extra. items42273857
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items42273857
Inc. avail. to common incl. extra. items42273857
Diluted net income42273857
Dilution adjustment--------
Diluted weighted average shares55545558
Diluted EPS excluding extraordinary itemsvalue per share0.770.510.700.98
Dividends per sharevalue per share0.360.360.360.36
Diluted normalized EPSvalue per share0.770.510.700.98